期刊
JOURNAL OF VIROLOGY
卷 84, 期 7, 页码 3362-3372出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.02028-09
关键词
-
类别
资金
- National Institutes of Health(NIH) [R01 AI077376-01, 1R21 AI082880-01]
- National Center for Research Resources [P51 RR000167]
- Research Facilities Improvement Program [RR15459-01, RR020141-01]
- Medical Research Council [G0501963] Funding Source: researchfish
- MRC [G0501963] Funding Source: UKRI
Live-attenuated vaccination with simian immunodeficiency virus (SIV) SIVmac239 Delta nef is the most successful vaccine product tested to date in macaques. However, the mechanisms that explain the efficacy of this vaccine remain largely unknown. We utilized an ex vivo viral suppression assay to assess the quality of the immune response in SIVmac239 Delta nef-immunized animals. Using major histocompatibility complex-matched Mauritian cynomolgus macaques, we did not detect SIV-specific functional immune responses in the blood by gamma interferon (IFN-gamma) enzyme-linked immunospot assay at select time points; however, we found that lung CD8(+) T cells, unlike blood CD8(+) T cells, effectively suppress virus replication by up to 80%. These results suggest that SIVmac239 Delta nef may be an effective vaccine because it elicits functional immunity at mucosal sites. Moreover, these results underscore the limitations of relying on immunological measurements from peripheral blood lymphocytes in studies of protective immunity to HIV/SIV.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据